Yahoo Finance

AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

Unprecedented imageability: 100% of patients received diagnostic results, with >99% successfully imaged on the first attempt without dilation AEYE-DS is already FDA-cleared for use with Topcon's ...
Healio

FDA clears use of Topcon retinal camera with EyeArt AI system for DR detection

Please provide your email address to receive an email when new articles are posted on . The EyeArt AI system is cleared for use with multiple retinal cameras by ...
Medindia

AEYE Health and Topcon Screen Announce Partnership to Enhance Point-of-Care Diabetic Retinopathy Screening with Best-in-Class AI Technology

NEW YORK, Oct. 27, 2023 /PRNewswire/ -- AEYE Health, the leader in artificial intelligence-based diagnostics for retinal imaging, and Topcon Screen, a leader in point-of-care diabetic eye exams, today ...
Seeking Alpha

AEYE Health in partnership with Topcon Healthcare, Inc, Announces Exceptional Usability and Clinical Efficacy for Autonomous Diabetic Retinopathy Screening

OAKLAND, N.J., Feb. 12, 2025 /PRNewswire/ -- AEYE Health, the premier provider of artificial intelligence-based diagnostics for retinal imaging along with Topcon Healthcare, Inc., a leading provider ...
Yahoo Finance

Retinal Surgery Devices Market Outlook Report 2025-2033: Revenues Set to Double, Reaching $4.83 Billion by 2033, Led by Topcon Corp., Alcon, and Carl Zeiss

The Retinal Surgery Devices Market is expected to reach US$ 4.84 billion in 2033 from US$ 2.48 billion in 2024, with a CAGR of 7.71% from 2025 to 2033. Some of the main reasons propelling the market ...